Oscar Health, Inc. (NYSE:OSCR) Shares Bought by GDS Wealth Management

GDS Wealth Management grew its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 1,545.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 345,817 shares of the company’s stock after purchasing an additional 324,798 shares during the period. GDS Wealth Management’s holdings in Oscar Health were worth $4,648,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of OSCR. State Street Corp grew its holdings in Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after purchasing an additional 291,335 shares during the period. Nordea Investment Management AB purchased a new stake in Oscar Health in the fourth quarter valued at approximately $1,056,000. Versor Investments LP purchased a new stake in Oscar Health in the third quarter valued at approximately $787,000. Janney Montgomery Scott LLC purchased a new stake in Oscar Health in the third quarter valued at approximately $988,000. Finally, Algert Global LLC grew its holdings in Oscar Health by 63.3% in the third quarter. Algert Global LLC now owns 369,685 shares of the company’s stock valued at $7,841,000 after purchasing an additional 143,346 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

OSCR has been the subject of a number of recent analyst reports. UBS Group began coverage on shares of Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price for the company. Jefferies Financial Group began coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target on the stock. Finally, Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $21.56.

Oscar Health Trading Up 0.7 %

NYSE OSCR opened at $16.72 on Tuesday. The stock has a market cap of $4.13 billion, a P/E ratio of -278.55, a PEG ratio of 0.67 and a beta of 1.73. The company’s fifty day simple moving average is $15.22 and its 200-day simple moving average is $16.85. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $12.84 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company’s revenue was up 68.3% on a year-over-year basis. During the same period in the prior year, the company earned ($0.29) earnings per share. Equities research analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Insider Activity at Oscar Health

In other Oscar Health news, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the sale, the chief accounting officer now owns 146,036 shares in the company, valued at $2,640,330.88. The trade was a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Vice Chairman Joshua Kushner bought 276,040 shares of the stock in a transaction on Monday, November 11th. The shares were acquired at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the purchase, the insider now owns 5,031,262 shares of the company’s stock, valued at $68,324,537.96. The trade was a 5.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 1,055,478 shares of company stock valued at $14,432,852 and have sold 103,610 shares valued at $1,847,519. 25.11% of the stock is currently owned by corporate insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.